paclitaxel has been researched along with Hepatic Failure in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (66.67) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abraham, I; Chacra, W; Danciu, OC; Kankanala, V; Remo, M | 1 |
Ikeda, M; Kubo, S; Nakamoto, S; Tsukioki, T; Yamamoto, M | 1 |
Franke, RM; Sparreboom, A | 1 |
Anak, S; Aydoğan, A; Celtik, C; Durmaz, O; Gökçe, S; Güllüoğlu, M; Oztürk, G; Sökücü, S; Türkoğlu, S; Unüvar, A; Yılmaz, G | 1 |
Choi, JS | 1 |
Hofer, S; Hunziker, S; Ludwig, CU; Tornillo, L | 1 |
Elsdon, M; Farrugia, D; Guglani, S; Owen, JR; Parmar, M | 1 |
Inui, K; Jiko, M; Okuda, M; Yano, I | 1 |
al Raheb, K; Bemer, M; Muhizi, J; Platini, C; Steinbach, G; Tomassini, E | 1 |
9 other study(ies) available for paclitaxel and Hepatic Failure
Article | Year |
---|---|
Hepatitis B Reactivation in a Patient Receiving Chemotherapy for Breast Cancer: A Case Report.
Topics: Antineoplastic Agents; Antiviral Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Liver Failure; Middle Aged; Paclitaxel; Tenofovir; Virus Activation | 2017 |
[Liver Atrophy and Failure Associated with Paclitaxel and Bevacizumab Combination Therapy for Metastatic Breast Cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Bevacizumab; Breast Neoplasms; Female; Humans; Liver; Liver Failure; Liver Neoplasms; Middle Aged; Paclitaxel | 2016 |
Inhibition of imatinib transport by uremic toxins during renal failure.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Benzamides; Biological Availability; Biological Transport; Humans; Imatinib Mesylate; Kidney Failure, Chronic; Liver Failure; Neoplasms; Organic Anion Transporters; Paclitaxel; Piperazines; Pyrimidines; Xenopus laevis | 2008 |
Human herpes virus type 8-associated Kaposi sarcoma in a pediatric liver transplant recipient.
Topics: Antineoplastic Agents; Female; Herpesvirus 8, Human; Humans; Immunosuppressive Agents; Infant; Liver Failure; Liver Transplantation; Lymphoproliferative Disorders; Paclitaxel; Prognosis; Sarcoma, Kaposi; Sirolimus; Treatment Outcome | 2011 |
Pharmacokinetics of paclitaxel in rabbits with carbon tetrachloride-induced hepatic failure.
Topics: Animals; Carbon Tetrachloride; Liver Failure; Male; Paclitaxel; Rabbits | 2002 |
Fatal herpes simplex virus hepatitis complicating chemotherapy with weekly docetaxel.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Fatal Outcome; Female; Hepatitis, Viral, Human; Herpes Simplex; Humans; Liver Failure; Middle Aged; Paclitaxel; Taxoids | 2003 |
Reversible life-threatening encephalopathy in the absence of hepatic failure following conventional doses of docetaxel.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Breast Neoplasms; Docetaxel; Female; Humans; Liver Failure; Paclitaxel; Taxoids | 2003 |
Altered pharmacokinetics of paclitaxel in experimental hepatic or renal failure.
Topics: Animals; Carbon Tetrachloride; Cytochrome P-450 Enzyme System; Liver Failure; Male; Metabolic Clearance Rate; Microsomes, Liver; Paclitaxel; Rats; Rats, Wistar; Renal Insufficiency; Steroid Hydroxylases | 2005 |
[Fulminant hepatocellular necrosis following administration of docetaxel].
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Female; Humans; Liver Failure; Middle Aged; Necrosis; Paclitaxel; Taxoids | 2001 |